Fibroid treatment showdown: surgery or embolization for better baby chances?
NCT ID NCT02577055
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two treatments for symptomatic uterine fibroids—surgery (myomectomy) and a minimally invasive procedure (uterine artery embolization)—to see which one better helps women get pregnant and have a live birth. It included 9 women aged 18 to 43 with fibroids larger than 3 cm who wanted to conceive. The main goal was to count live births within one year of trying to get pregnant, starting 6 months after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEIOMYOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Département de Médecine de la Reproduction, Centre Hospitalier Régionnal Universitaire de Montpellier
Montpellier, 34000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A drug that may curb bleeding during fibroid surgery faces its first big test
- Could a common cholesterol drug shrink uterine fibroids?
- Single incision vs. multiple: which hysterectomy technique gets you home faster?
- Vitamin cocktail may shrink fibroids, reduce surgery need
- Stiffness check could boost fibroid treatment success
- 700 women followed for over a decade to see which fibroid treatments last longest